These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


167 related items for PubMed ID: 6934558

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Blood platelet monoamine oxidase activity in anergic schizophrenics.
    Shaskan EG, Becker RE.
    Natl Inst Drug Abuse Res Monogr Ser; 1975 Nov; (3):29-35. PubMed ID: 1233383
    [Abstract] [Full Text] [Related]

  • 23. Monoamine oxidase in schizophrenia: an overview.
    Wyatt RJ, Potkin SG, Bridge TP, Phelps BH, Wise CD.
    Schizophr Bull; 1980 Nov; 6(2):199-207. PubMed ID: 7375851
    [Abstract] [Full Text] [Related]

  • 24. Platelet monoamine oxidase activity in acute schizophrenia.
    Carpenter WT, Murphy DL, Wyatt RJ.
    Am J Psychiatry; 1975 Apr; 132(4):438-41. PubMed ID: 1119597
    [Abstract] [Full Text] [Related]

  • 25. Effect of nomifensine on platelet monoamine oxidase activity in chronic schizophrenic patients.
    Filinger EJ.
    Gen Pharmacol; 1989 Apr; 20(6):821-2. PubMed ID: 2591711
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Platelet monoamine oxidase in a pedigree with schizophrenia: an interlaboratory project.
    Ask AL, Böök JA, Heyden T, Ross SB, Unge C, Wetterberg L, Eiduson S, Kobayashi K.
    Clin Genet; 1979 Apr; 15(4):289-99. PubMed ID: 436326
    [Abstract] [Full Text] [Related]

  • 32. Further studies on the endogenous inhibitor of monoamine oxidase in schizophrenic plasma.
    Vogel WH, Ladman RK, Berrettini WH.
    Schizophr Bull; 1980 Apr; 6(2):232-4. PubMed ID: 7375855
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Platelet MAO and family history of schizophrenia: some methodological considerations.
    Baron M.
    Psychiatry Res; 1983 Jan; 8(1):79-81. PubMed ID: 6572990
    [No Abstract] [Full Text] [Related]

  • 35. Platelet MAO and family history of schizophrenia: method and madness.
    Meltzer HY, Luchins DJ.
    Psychiatry Res; 1983 Jan; 8(1):83-5. PubMed ID: 6572991
    [No Abstract] [Full Text] [Related]

  • 36. Schizophrenic outcome in late life: symptom state and platelet monoamine oxidase activity.
    Bridge TP, Jeste DV, Wise CD, Potkin SG, Phelps BH, Wyatt RJ.
    Psychiatry Res; 1984 Feb; 11(2):91-7. PubMed ID: 6143337
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Reduction of blood platelet monoamine oxidase activity in schizophrenic patients on phenothiazines.
    Takahashi S, Yamane H, Tani N.
    Folia Psychiatr Neurol Jpn; 1975 Feb; 29(3):207-14. PubMed ID: 2524
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.